Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Mediated”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00391287
What this trial is testing

Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure

Who this might be right for
Pure Red-Cell AplasiaChronic Kidney Failure
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 15,334
Early research (Phase 1)Study completedNCT02983006
What this trial is testing

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
NYU Langone Health 12
Testing effectiveness (Phase 2)Study completedNCT01134510
What this trial is testing

Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection

Who this might be right for
Kidney Transplantation
Stanley Jordan, MD 20
Testing effectiveness (Phase 2)Study completedNCT02936479
What this trial is testing

C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection

Who this might be right for
Antibody Mediated Rejection of Kidney Transplant
NYU Langone Health 1
Testing effectiveness (Phase 2)Study completedNCT01567085
What this trial is testing

Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor

Who this might be right for
Stage V Chronic Kidney Disease
Alexion Pharmaceuticals, Inc. 80
Testing effectiveness (Phase 2)Looking for participantsNCT07641426
What this trial is testing

A Two Part Dose-escalation Safety and Efficacy Study of CID-103 in Adults With Active and Chronic Active Renal Allograft Antibody Mediated Rejection (ABMR).

Who this might be right for
Antibody Mediated Rejection
CASI pharmaceuticals, Inc. 58
Not applicableStudy completedNCT01189123
What this trial is testing

Cell Mediated Immunity in Older Adults

Who this might be right for
Immunity to Influenza Vaccine
Vanderbilt University 105
Large-scale testing (Phase 3)Ended earlyNCT03221842
What this trial is testing

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
CSL Behring 63
Testing effectiveness (Phase 2)Study completedNCT03388008
What this trial is testing

Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation

Who this might be right for
Lung Transplant RejectionAntibody-mediated Rejection
Washington University School of Medicine 27
Not applicableLooking for participantsNCT02812290
What this trial is testing

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Who this might be right for
Lung Transplant Rejection
University of Alberta 700
Not applicableStudy completedNCT04367610
What this trial is testing

Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection

Who this might be right for
Antibody-mediated RejectionKidney Transplant RejectionGraft Loss
Istanbul University 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07752264
What this trial is testing

A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy

Who this might be right for
Refractory Immune-mediated Necrotizing Myopathy
Nanjing IASO Biotechnology Co., Ltd. 27
Testing effectiveness (Phase 2)Ended earlyNCT01630538
What this trial is testing

Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants

Who this might be right for
Antibody Mediated Rejection
University of Manitoba 4
Not applicableStudy completedNCT03098238
What this trial is testing

Endothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney Transplantation

Who this might be right for
Renal Transplantation
University Hospital, Montpellier 249
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06886646
What this trial is testing

Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation

Who this might be right for
Chronic Antibody-mediated Rejection (cABMR)
Assistance Publique - Hôpitaux de Paris 22
Testing effectiveness (Phase 2)Looking for participantsNCT06599697
What this trial is testing

The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy

Who this might be right for
Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy
University of Alabama at Birmingham 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07613359
What this trial is testing

Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant

Who this might be right for
Antibody-Mediated Rejection (AMR)
Takeda 36
Not applicableStudy completedNCT01288014
What this trial is testing

Cytokine Production and Immunity to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster Vaccine

Who this might be right for
Immunity; Defect Due to Antibody or Cell Mediated Immune Defect
Columbia University 26
Not applicableNot Yet RecruitingNCT07737470
What this trial is testing

Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research

Who this might be right for
PericarditisTako-TSUBO CardiomyopathyMyocarditis+12 more
Assistance Publique - Hôpitaux de Paris 300
Not applicableNot Yet RecruitingNCT04496037
What this trial is testing

Mechanistic Evaluation of Treatments for Acute Antibody-Mediated Rejection of the Kidney Transplant

Who this might be right for
Transplant; Complication, Rejection
Imperial College London 170
Next Page